Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-03 Purchase |
2022-06-07 1:52 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
4,200 | $4.923 | $20,677 | 601,004 (Indirect Direct) |
View |
| 2022-06-07 Purchase |
2022-06-07 12:22 pm |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
200 | $4.56 | $912 | 18,290 (Direct) |
View |
| 2022-06-02 Purchase |
2022-06-06 1:35 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,000 | $4.6878 | $4,688 | 596,804 (Indirect Direct) |
View |
| 2022-06-01 Purchase |
2022-06-03 4:03 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
9,213 | $4.4635 | $41,122 | 595,804 (Indirect Direct) |
View |
| 2022-06-01 Purchase |
2022-06-03 06:58 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
200 | $4.6 | $920 | 514,359 (Direct) |
View |
| 2022-05-27 Purchase |
2022-06-01 4:30 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
10,957 | $3.6134 | $39,592 | 586,591 (Indirect Direct) |
View |
| 2022-05-26 Purchase |
2022-05-31 5:18 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
4,950 | $3.5079 | $17,364 | 575,634 (Indirect Direct) |
View |
| 2022-05-26 Sale |
2022-05-31 5:18 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
2,000 | $3.4378 | $6,876 | 575,634 (Indirect Direct) |
View |
| 2022-05-26 Purchase |
2022-05-27 10:23 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
2,700 | $3.5163 | $9,494 | 514,159 (Direct) |
View |
| 2022-05-02 Purchase |
2022-05-02 5:14 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
400 | $3.947 | $1,579 | 511,459 (Direct) |
View |
| 2022-04-08 Purchase |
2022-04-11 10:47 am |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
7,600 | $5.71 | $43,396 | 18,090 (Direct) |
View |
| 2022-04-06 Purchase |
2022-04-08 4:23 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
2,500 | $5.66 | $14,150 | 572,684 (Indirect Direct) |
View |
| 2022-04-05 Purchase |
2022-04-07 4:15 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
46,000 | $5.7096 | $262,640 | 570,184 (Indirect Direct) |
View |
| 2022-03-29 Purchase |
2022-04-01 4:54 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
15,700 | $4.8464 | $76,088 | 524,184 (Indirect Direct) |
View |
| 2022-03-01 Purchase |
2022-03-29 4:52 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
155,950 | $5.0921 | $794,110 | 508,484 (Indirect Direct) |
View |
| 2022-01-24 Purchase |
2022-01-24 5:03 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
1,470 | $3.4 | $4,998 | 498,621 (Direct) |
View |
| 2022-01-05 Purchase |
2022-01-05 4:52 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
2,000 | $3.85 | $7,700 | 497,151 (Direct) |
View |
| 2021-12-01 Purchase |
2021-12-02 10:00 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
799 | $5.5 | $4,395 | 495,151 (Direct) |
View |
| 2021-11-23 Purchase |
2021-11-23 5:15 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
2,500 | $6 | $15,000 | 494,352 (Direct) |
View |
| 2021-11-22 Purchase |
2021-11-22 5:29 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
396 | $6.31 | $2,499 | 491,852 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-22 12:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
4,000 | $6.6565 | $26,626 | 496,299 (Indirect Direct) |
View |
| 2021-11-16 Purchase |
2021-11-16 6:07 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
4,500 | $6.7113 | $30,201 | 491,456 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-16 5:23 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
7,826 | $6.7252 | $52,632 | 492,299 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-18 Option Award |
2022-03-22 5:11 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
12,438 | $0 | 508,736 (Direct) |
View |
| 2022-03-18 Option Award |
2022-03-22 5:08 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
12,438 | $0 | 511,059 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-16 4:24 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
10,490 | $0 | 10,490 (Direct) |
View |
Ownership |
2021-11-16 4:21 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 5:42 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
10,490 | $0 | 10,490 (Direct) |
View |
Ownership |
2021-11-08 5:40 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
0 | $0 | 0 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 5:38 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
10,490 | $0 | 10,490 (Direct) |
View |
Ownership |
2021-11-08 5:36 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 5:35 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
335,538 | $0 | 484,474 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 5:32 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
25,236 | $0 | 25,236 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 5:30 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
335,538 | $0 | 486,956 (Direct) |
View |
Ownership |
2021-03-19 5:07 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-19 5:05 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
1,760,876,961 | $0 | 1,769,661,356 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-19 5:03 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
1,760,876,961 | $0 | 1,779,588,627 (Direct) |
View |
| 2020-11-23 Other |
2020-11-24 4:11 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
18,661,666 | $0 | 37,373,332 (Direct) |
View |
| 2020-11-23 Other |
2020-11-24 4:02 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
8,375,671 | $0 | 17,160,066 (Direct) |
View |